Neuphoria Therapeutics Inc. – Common Stock (NASDAQ:NEUP) Price Target Raised to $21.00 at HC Wainwright

Neuphoria Therapeutics Inc. – Common Stock (NASDAQ:NEUP) had its target price upped by HC Wainwright from $8.00 to $21.00 in a research note published on Tuesday morning,Benzinga reports. The firm currently has a buy rating on the stock.

Neuphoria Therapeutics Inc. – Common Stock Price Performance

NEUP stock opened at $5.09 on Tuesday. Neuphoria Therapeutics Inc. – Common Stock has a 1-year low of $2.12 and a 1-year high of $16.08.

Neuphoria Therapeutics Inc. – Common Stock Company Profile

Neuphoria Therapeutics, Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.